Cargando…

Clinical strategies for securing negative proximal margin in early gastric cancer

Securing an appropriate proximal resection margin (PRM) is crucial for oncological safety in treating gastric cancer. This study investigated the clinicopathological characteristics of patients with incomplete PRM length of <2 cm in early gastric cancer. Clinicopathological data of 1,493 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Jae Hun, Im, Dong Won, Ryu, Dae-Gon, Choi, Cheol Woong, Kim, Su Jin, Hwang, Sun-Hwi, Lee, Si-Hak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552986/
https://www.ncbi.nlm.nih.gov/pubmed/37800787
http://dx.doi.org/10.1097/MD.0000000000035393
_version_ 1785116068168073216
author Chung, Jae Hun
Im, Dong Won
Ryu, Dae-Gon
Choi, Cheol Woong
Kim, Su Jin
Hwang, Sun-Hwi
Lee, Si-Hak
author_facet Chung, Jae Hun
Im, Dong Won
Ryu, Dae-Gon
Choi, Cheol Woong
Kim, Su Jin
Hwang, Sun-Hwi
Lee, Si-Hak
author_sort Chung, Jae Hun
collection PubMed
description Securing an appropriate proximal resection margin (PRM) is crucial for oncological safety in treating gastric cancer. This study investigated the clinicopathological characteristics of patients with incomplete PRM length of <2 cm in early gastric cancer. Clinicopathological data of 1,493 patients who underwent subtotal gastrectomy for early gastric cancer in 2012 to 2021 were retrospectively reviewed. Patients were divided into the PRM length of <2 cm and ≥2 cm groups based on pathological results. Univariate and multivariate analyses evaluated factors for incomplete PRM length. Factors related to patients with a relative PRM positive were also analyzed. The proportion of patients with a PRM length of <2 cm was 17.9% (267/1,493). Multivariate regression analysis revealed that age <50, preoperative endoscopic size of ≥3 cm, size discrepancy of ≥2 cm, and midbody tumor with a lesser curvature significantly contributed to the PRM length of <2 cm. Twenty-four patients had a relative PRM positive (24/1493, 1.6%). An incomplete PRM was the only risk factor for a positive relative PRM. Surgical treatment for early gastric cancer requires an accurate preoperative endoscopic tumor size and location evaluation. A more aggressive resection is recommended for patients with age <50, preoperative endoscopic size of ≥3 cm, size discrepancy of ≥2 cm, and midbody tumor with a lesser curvature.
format Online
Article
Text
id pubmed-10552986
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105529862023-10-06 Clinical strategies for securing negative proximal margin in early gastric cancer Chung, Jae Hun Im, Dong Won Ryu, Dae-Gon Choi, Cheol Woong Kim, Su Jin Hwang, Sun-Hwi Lee, Si-Hak Medicine (Baltimore) 7100 Securing an appropriate proximal resection margin (PRM) is crucial for oncological safety in treating gastric cancer. This study investigated the clinicopathological characteristics of patients with incomplete PRM length of <2 cm in early gastric cancer. Clinicopathological data of 1,493 patients who underwent subtotal gastrectomy for early gastric cancer in 2012 to 2021 were retrospectively reviewed. Patients were divided into the PRM length of <2 cm and ≥2 cm groups based on pathological results. Univariate and multivariate analyses evaluated factors for incomplete PRM length. Factors related to patients with a relative PRM positive were also analyzed. The proportion of patients with a PRM length of <2 cm was 17.9% (267/1,493). Multivariate regression analysis revealed that age <50, preoperative endoscopic size of ≥3 cm, size discrepancy of ≥2 cm, and midbody tumor with a lesser curvature significantly contributed to the PRM length of <2 cm. Twenty-four patients had a relative PRM positive (24/1493, 1.6%). An incomplete PRM was the only risk factor for a positive relative PRM. Surgical treatment for early gastric cancer requires an accurate preoperative endoscopic tumor size and location evaluation. A more aggressive resection is recommended for patients with age <50, preoperative endoscopic size of ≥3 cm, size discrepancy of ≥2 cm, and midbody tumor with a lesser curvature. Lippincott Williams & Wilkins 2023-10-06 /pmc/articles/PMC10552986/ /pubmed/37800787 http://dx.doi.org/10.1097/MD.0000000000035393 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle 7100
Chung, Jae Hun
Im, Dong Won
Ryu, Dae-Gon
Choi, Cheol Woong
Kim, Su Jin
Hwang, Sun-Hwi
Lee, Si-Hak
Clinical strategies for securing negative proximal margin in early gastric cancer
title Clinical strategies for securing negative proximal margin in early gastric cancer
title_full Clinical strategies for securing negative proximal margin in early gastric cancer
title_fullStr Clinical strategies for securing negative proximal margin in early gastric cancer
title_full_unstemmed Clinical strategies for securing negative proximal margin in early gastric cancer
title_short Clinical strategies for securing negative proximal margin in early gastric cancer
title_sort clinical strategies for securing negative proximal margin in early gastric cancer
topic 7100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552986/
https://www.ncbi.nlm.nih.gov/pubmed/37800787
http://dx.doi.org/10.1097/MD.0000000000035393
work_keys_str_mv AT chungjaehun clinicalstrategiesforsecuringnegativeproximalmargininearlygastriccancer
AT imdongwon clinicalstrategiesforsecuringnegativeproximalmargininearlygastriccancer
AT ryudaegon clinicalstrategiesforsecuringnegativeproximalmargininearlygastriccancer
AT choicheolwoong clinicalstrategiesforsecuringnegativeproximalmargininearlygastriccancer
AT kimsujin clinicalstrategiesforsecuringnegativeproximalmargininearlygastriccancer
AT hwangsunhwi clinicalstrategiesforsecuringnegativeproximalmargininearlygastriccancer
AT leesihak clinicalstrategiesforsecuringnegativeproximalmargininearlygastriccancer